Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiota and immunometabolism in obesity.

Gut microbes·2026
Same author

Food spoilage and packaging solutions: key Mediterranean case studies.

Food research international (Ottawa, Ont.)·2026
Same author

Safety and Tolerability of the Gut Bacterium <i>Phascolarctobacterium faecium</i> DSM 32890.

Nutrients·2026
Same author

DPPPRED-IV: An Ensembled QSAR-Based Web Server for the Prediction of Dipeptidyl Peptidase 4 Inhibitors.

International journal of molecular sciences·2025
Same author

Gut commensal Phascolarctobacterium faecium retunes innate immunity to mitigate obesity and metabolic disease in mice.

Nature microbiology·2025
Same author

Obesity and the gut microbiota: implications of neuroendocrine and immune signaling.

The FEBS journal·2024

Related Experiment Video

Updated: May 14, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Host genotype, intestinal microbiota and inflammatory disorders.

Marta Olivares1, J Moisés Laparra, Yolanda Sanz

  • 1Microbial Ecology and Nutrition Research Group, Institute of Agrochemistry and Food Technology, National Research Council (IATA-CSIC), Avenida Agustín Escardino, 7. 46980 Paterna, Valencia, Spain.

The British Journal of Nutrition
|January 31, 2013
PubMed
Summary

Early life gut microbiota colonization influences immune system development and disease risk. Host genetics and microbial composition interact, impacting inflammatory and atopic conditions.

More Related Videos

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Related Experiment Videos

Last Updated: May 14, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Area of Science:

  • Immunology
  • Microbiology
  • Genetics

Background:

  • Intestinal microbiota plays a crucial role in immune responses and disease risk.
  • Early life gut colonization is vital for immune system maturation, influenced by genetics and environment.
  • Imbalances in microbiota and genetic factors are implicated in inflammatory bowel disease, atopic diseases, and celiac disease.

Purpose of the Study:

  • To explore the intricate relationship between host genetics, intestinal microbiota, and immune-mediated diseases.
  • To highlight the significance of early life gut colonization in immune system development and disease susceptibility.

Main Methods:

  • Review of existing research on host genetics and intestinal microbiota interactions.
  • Analysis of genetic polymorphisms (e.g., CARD15, TLR4, CD14, HLA-DQ2/DQ8) and their association with microbiota composition and disease.
  • Consideration of environmental factors influencing gut colonization and immune responses.

Main Results:

  • Genetic factors (e.g., CARD15) influence inflammatory bowel disease pathogenesis through altered responses to microbiota.
  • Associations between microbiota imbalances, genetic factors (e.g., TLR4, CD14), and atopic diseases are suggested but require further validation.
  • Host genetics (e.g., HLA-DQ) may impact early life microbial colonization, as seen in infants at risk for celiac disease.

Conclusions:

  • Host genetics and intestinal microbiota are key players in immune system regulation and susceptibility to inflammatory disorders.
  • Understanding these complex host-microbe interactions is critical for defining disease pathogenesis.
  • Future research should integrate host genetics and microbiota data to elucidate their roles in inflammatory conditions.